I'm actually personally surprised that they had that much revenue in the past. The lack of revenue last year doesn't surprise me in the least. This company is poised to move in a positive direction in that regard in the near future, and 2014's numbers should come as basically "no surprise" to anyone. Everyone is entitled to their opinions, but I have good faith that the sky is the limit for this stock (especially given the current political climate and groundswell of support for medical MJ), with minimal downside risk. Just my .02.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.